Physician profile
Elizabeth Lu
NPI 1568496172
$699.31
in general payments reported to CMS, 2019-2025
16 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $68.94 · 2022: $73.61 · 2024: $138 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $118.34 | 2024-2025 | |
| Smith+Nephew, INC. | $86.77 | 2019-2024 | Collagenase Santyl, Regranex |
| Paratek Pharmaceuticals, INC. | $74.99 | 2024-2025 | Nuzyra |
| Organogenesis INC. | $68.94 | 2020 | |
| Merck Sharp & Dohme LLC | $58.26 | 2019 | |
| Horizon Therapeutics Plc | $48.57 | 2019-2022 | |
| Orthofix Medical, INC. | $38.26 | 2019 | |
| Reprise Biomedical, INC. | $30.90 | 2025 | Miro3d |
| Boston Scientific Corporation | $30.46 | 2019 | |
| Averitas Pharma INC. | $26.25 | 2025 | Qutenza |
| Advanced Oxygen Therapy INC. | $25.15 | 2025 | Topical Oxygen Chamber For Extremities |
| Bioventus LLC | $24.72 | 2019 | |
| Stimlabs LLC | $21.21 | 2025 | Geistlich Derma-Gide |
| Kyowa Kirin, INC. | $17.37 | 2025 | |
| Grt US Holding, INC. | $14.90 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.22 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.